MetLife, Inc. (MET)
| Market Cap | 54.24B +5.7% |
| Revenue (ttm) | 77.58B +5.6% |
| Net Income | 3.43B -19.6% |
| EPS | 5.16 -16.0% |
| Shares Out | 643.44M |
| PE Ratio | 16.00 |
| Forward PE | 8.27 |
| Dividend | $2.27 (2.69%) |
| Ex-Dividend Date | May 12, 2026 |
| Volume | 4,178,538 |
| Open | 82.91 |
| Previous Close | 82.51 |
| Day's Range | 82.19 - 84.38 |
| 52-Week Range | 67.33 - 84.38 |
| Beta | 0.78 |
| Analysts | Buy |
| Price Target | 91.69 (+8.77%) |
| Earnings Date | May 6, 2026 |
About MET
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative s... [Read more]
Financial Performance
In 2025, MetLife's revenue was $77.08 billion, an increase of 8.59% compared to the previous year's $70.98 billion. Earnings were $3.17 billion, a decrease of -24.92%.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for MET stock is "Buy." The 12-month stock price target is $91.69, which is an increase of 8.77% from the latest price.
News
MetLife price target raised to $93 from $89 at Morgan Stanley
Morgan Stanley analyst Bob Huang raised the firm’s price target on MetLife (MET) to $93 from $89 and keeps an Overweight rating on the shares. Results were “generally strong” for…
MetLife Declares Second Quarter 2026 Preferred Stock Dividends
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.31190376 per share on the company's floating...
MetLife price target raised to $98 from $87 at Keefe Bruyette
Keefe Bruyette analyst Ryan Krueger raised the firm’s price target on MetLife (MET) to $98 from $87 and keeps an Outperform rating on the shares.
MetLife and Global Citizen Launch “Footwork for Futures” Social Media Challenge to Help Expand Access to Education and Sports
NEW YORK--(BUSINESS WIRE)--Today, MetLife and Global Citizen announced Footwork for Futures, a global soccer-themed social media challenge that supports children's access to quality education and spor...
MetLife price target raised to $96 from $95 at JPMorgan
JPMorgan analyst Jimmy Bhullar raised the firm’s price target on MetLife (MET) to $96 from $95 and keeps an Overweight rating on the shares. The firm upped estimates post the…
MetLife price target raised to $95 from $90 at Wells Fargo
Wells Fargo raised the firm’s price target on MetLife (MET) to $95 from $90 and keeps an Overweight rating on the shares. The firm is also updating estimates to incorporate…
MetLife Q1 Earnings Call Highlights
MetLife NYSE: MET reported a strong start to 2026, with executives telling analysts that first-quarter results reflected broad-based growth across its operating businesses, favorable underwriting tren...
MetLife price target raised to $95 from $93 at Mizuho
Mizuho analyst Yaron Kinar raised the firm’s price target on MetLife (MET) to $95 from $93 and keeps an Outperform rating on the shares.
MetLife Earnings Call Transcript: Q1 2026
Adjusted earnings rose 18% year-over-year to $1.6 billion, with all segments posting growth and strong capital management. The quarter featured robust sales across regions, disciplined expense control, and continued execution of the New Frontier strategy, supporting a positive outlook.
MetLife Earnings release: Q1 2026
MetLife released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
MetLife Slides: Q1 2026
MetLife has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
MetLife Quarterly report: Q1 2026
MetLife has published its Q1 2026 quarterly earnings report on May 7, 2026.
MetLife price target raised to $93 from $89 at Barclays
Barclays analyst Alex Scott raised the firm’s price target on MetLife (MET) to $93 from $89 and keeps an Overweight rating on the shares.
MetLife reports Q1 adjusted EPS $2.42, consensus $2.27
Reports Q1 revenue $19.07B, consensus $19.42B. Comment from Michel Khalaf, President and Chief Executive Officer: “MetLife (MET) delivered exceptional performance in the first quarter, with adjusted e...
MetLife CFO John McCallion Provides First Quarter 2026 Financial Update Video
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided ...
MetLife Announces 1Q 2026 Results
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced its first quarter 2026 results. Earnings Return Per Share on Equity (ROE) 1Q 2026 1Q 2026 Net Income $1.74 ROE 18.2% Adjusted...
MetLife Proxy statement: Proxy filing
MetLife filed a proxy statement on April 29, 2026, providing details for shareholder voting and corporate governance matters.
MetLife Proxy statement: Proxy filing
MetLife filed a proxy statement on April 29, 2026, providing details for shareholder voting and corporate governance matters.
MetLife raises quarterly dividend by 4.4% to 59.25c per share
The dividend will be payable on June 9, 2026, to shareholders of record as of May 12, 2026.
MetLife Increases Common Stock Dividend by 4.4%
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a second quarter 2026 common stock dividend of $0.5925 per share, an increase of 4.4% from...
MetLife recommends shareholders reject “mini tender” offer by Potemkin
MetLife (MET) has received notice of an unsolicited mini-tender offer by Potemkin to purchase up to 100,000 shares of MetLife common stock from MetLife shareholders. The offer is for approximately…
MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (“Potemkin”) to purchase up to 100,000 shares o...
MetLife price target lowered to $99 from $103 at BofA
BofA lowered the firm’s price target on MetLife (MET) to $99 from $103 and keeps a Buy rating on the shares. The firm adjusted price target among its U.S. insurance…
MetLife price target lowered to $93 from $100 at Mizuho
Mizuho analyst Yaron Kinar lowered the firm’s price target on MetLife (MET) to $93 from $100 and keeps an Outperform rating on the shares. The firm adjusted estimates and targets…
MetLife price target raised to $96 from $95 at Evercore ISI
Evercore ISI raised the firm’s price target on MetLife (MET) to $96 from $95 and keeps an In Line rating on the shares. The firm adjusted estimates ahead of earnings.